Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry-Reference-Cited by-同舟云学术

Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry

Published:2023-03 Issue:1 Volume:65 Page:
ISSN:0031-0808
Container-title:Panminerva Medica
language:
Short-container-title:Panminerva Med

Author:

CIRILLO Plinio,DI SERAFINO Luigi,GAMRA Habib,ZIMARINO Marco,BARBATO Emanuele,BRIGUORI Carlo,AMAT-SANTOS Ignatio J.,CHIEFFO Alaide,ERGLIS Andrejs,GIL Robert J.,KEDEV Sasko A.,PETROV Ivo,RADICO Francesco,NIGLIO Tullio,NAKAMURA Sunao,COSTA Ricardo A.,KANIC Vojko,PERFETTI Matteo,PELLICANO Mariano,MARIC Kristina,TESORIO Tullio,VUKCEVIC Vladan,ESPOSITO Giovanni,STANKOVIC Goran,

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R41Y9999N00A22051301

Reference22 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials

3. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

4. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting

5. Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk;American Journal of Cardiovascular Drugs;2024-06-13

2. Techniques and Evidence for Percutaneous Coronary Intervention for Coronary Bifurcation Lesions: An Ongoing Journey;Cardiology Discovery;2022-09